Theranos Posed 'Immediate Jeopardy' To Patients, Feds Say
Poor laboratory practices at Theranos Inc. placed patients in "immediate jeopardy" and may warrant revoking the company's Medicare billing privileges, federal regulators said in a letter released Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article